Completion of second tranche set to accelerate commercial launch of revolutionary enzymatic DNA printing technology.
DNA Script closes $200 million Series C financing
Posted in biotech/medical
Posted in biotech/medical
Completion of second tranche set to accelerate commercial launch of revolutionary enzymatic DNA printing technology.